Erratum to “Periorbital edema associated with alpelisib” [Cancer Treatment and Research Communications 32 (2022) 100596] (Cancer Treatment and Research Communications (2022) 32, (S2468294222000867), (10.1016/j.ctarc.2022.100596))

Elizabeth A. Dao; Saira J. George; Meghan M. Heberton; Omar Pacha; Craig A. Kovitz; Anisha B. Patel; Rhea M. Phillips

doi:10.1016/j.ctarc.2022.100654

Erratum to “Periorbital edema associated with alpelisib” [Cancer Treatment and Research Communications 32 (2022) 100596] (Cancer Treatment and Research Communications (2022) 32, (S2468294222000867), (10.1016/j.ctarc.2022.100596))

Elizabeth A. Dao, Saira J. George, Meghan M. Heberton, Omar Pacha, Craig A. Kovitz, Anisha B. Patel, Rhea M. Phillips

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

Declaration of Patient Consent statement was not included in the published version of this article. The appropriate Declaration of Patient Consent statements, provided by the Authors, is included below. “The authors declare that they have obtained consent from the patient” The Publisher would like to apologise for any inconvenience caused.

Original language	English (US)
Article number	100654
Journal	Cancer Treatment and Research Communications
Volume	33
DOIs	https://doi.org/10.1016/j.ctarc.2022.100654
State	Published - Jan 2022
Externally published	Yes

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1016/j.ctarc.2022.100654

Fingerprint

Dive into the research topics of 'Erratum to “Periorbital edema associated with alpelisib” [Cancer Treatment and Research Communications 32 (2022) 100596] (Cancer Treatment and Research Communications (2022) 32, (S2468294222000867), (10.1016/j.ctarc.2022.100596))'. Together they form a unique fingerprint.

Cite this

Dao, E. A., George, S. J., Heberton, M. M., Pacha, O., Kovitz, C. A., Patel, A. B., & Phillips, R. M. (2022). Erratum to “Periorbital edema associated with alpelisib” [Cancer Treatment and Research Communications 32 (2022) 100596] (Cancer Treatment and Research Communications (2022) 32, (S2468294222000867), (10.1016/j.ctarc.2022.100596)). Cancer Treatment and Research Communications, 33, Article 100654. https://doi.org/10.1016/j.ctarc.2022.100654

Erratum to “Periorbital edema associated with alpelisib” [Cancer Treatment and Research Communications 32 (2022) 100596] (Cancer Treatment and Research Communications (2022) 32, (S2468294222000867), (10.1016/j.ctarc.2022.100596)). / Dao, Elizabeth A.; George, Saira J.; Heberton, Meghan M. et al.
In: Cancer Treatment and Research Communications, Vol. 33, 100654, 01.2022.

Research output: Contribution to journal › Comment/debate › peer-review

Dao, EA, George, SJ, Heberton, MM, Pacha, O, Kovitz, CA, Patel, AB & Phillips, RM 2022, 'Erratum to “Periorbital edema associated with alpelisib” [Cancer Treatment and Research Communications 32 (2022) 100596] (Cancer Treatment and Research Communications (2022) 32, (S2468294222000867), (10.1016/j.ctarc.2022.100596))', Cancer Treatment and Research Communications, vol. 33, 100654. https://doi.org/10.1016/j.ctarc.2022.100654

Dao EA, George SJ, Heberton MM, Pacha O, Kovitz CA, Patel AB et al. Erratum to “Periorbital edema associated with alpelisib” [Cancer Treatment and Research Communications 32 (2022) 100596] (Cancer Treatment and Research Communications (2022) 32, (S2468294222000867), (10.1016/j.ctarc.2022.100596)). Cancer Treatment and Research Communications. 2022 Jan;33:100654. doi: 10.1016/j.ctarc.2022.100654

@article{d4ad6c1897ed43fca46fed0bcafb9086,

title = "Erratum to “Periorbital edema associated with alpelisib” [Cancer Treatment and Research Communications 32 (2022) 100596] (Cancer Treatment and Research Communications (2022) 32, (S2468294222000867), (10.1016/j.ctarc.2022.100596))",

abstract = "Declaration of Patient Consent statement was not included in the published version of this article. The appropriate Declaration of Patient Consent statements, provided by the Authors, is included below. “The authors declare that they have obtained consent from the patient” The Publisher would like to apologise for any inconvenience caused.",

author = "Dao, {Elizabeth A.} and George, {Saira J.} and Heberton, {Meghan M.} and Omar Pacha and Kovitz, {Craig A.} and Patel, {Anisha B.} and Phillips, {Rhea M.}",

note = "Publisher Copyright: {\textcopyright} 2022 The Authors",

year = "2022",

month = jan,

doi = "10.1016/j.ctarc.2022.100654",

language = "English (US)",

volume = "33",

journal = "Cancer Treatment and Research Communications",

issn = "2213-0896",

publisher = "Elsevier Ltd",

}

TY - JOUR

T1 - Erratum to “Periorbital edema associated with alpelisib” [Cancer Treatment and Research Communications 32 (2022) 100596] (Cancer Treatment and Research Communications (2022) 32, (S2468294222000867), (10.1016/j.ctarc.2022.100596))

AU - Dao, Elizabeth A.

AU - George, Saira J.

AU - Heberton, Meghan M.

AU - Pacha, Omar

AU - Kovitz, Craig A.

AU - Patel, Anisha B.

AU - Phillips, Rhea M.

PY - 2022/1

Y1 - 2022/1

N2 - Declaration of Patient Consent statement was not included in the published version of this article. The appropriate Declaration of Patient Consent statements, provided by the Authors, is included below. “The authors declare that they have obtained consent from the patient” The Publisher would like to apologise for any inconvenience caused.

AB - Declaration of Patient Consent statement was not included in the published version of this article. The appropriate Declaration of Patient Consent statements, provided by the Authors, is included below. “The authors declare that they have obtained consent from the patient” The Publisher would like to apologise for any inconvenience caused.

UR - http://www.scopus.com/inward/record.url?scp=85143917568&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85143917568&partnerID=8YFLogxK

U2 - 10.1016/j.ctarc.2022.100654

DO - 10.1016/j.ctarc.2022.100654

M3 - Comment/debate

C2 - 36463021

AN - SCOPUS:85143917568

SN - 2213-0896

VL - 33

JO - Cancer Treatment and Research Communications

JF - Cancer Treatment and Research Communications

M1 - 100654

ER -

Erratum to “Periorbital edema associated with alpelisib” [Cancer Treatment and Research Communications 32 (2022) 100596] (Cancer Treatment and Research Communications (2022) 32, (S2468294222000867), (10.1016/j.ctarc.2022.100596))

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this